The Catholic University of Korea, Seoul St.Mary's Hospital
Seoul, Korea, Republic of
University hospital in Seoul
222 Banpo-daero, Banpo-dong, Seocho-gu, Seoul
About The Catholic University of Korea, Seoul St.Mary's Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
The Catholic University of Korea
47
Hoffmann-La Roche
35
Janssen Research & Development, LLC
33
Seoul St. Mary's Hospital
33
Pfizer
30
Seung-Jung Park
30
Chong Kun Dang Pharmaceutical
21
Boehringer Ingelheim
17
Eli Lilly and Company
16
Takeda
14
Genexine, Inc.
13
Clinical Trials at The Catholic University of Korea, Seoul St.Mary's Hospital
During the past decade, The Catholic University of Korea, Seoul St.Mary's Hospital conducted 500 clinical trials. In the 10-year time frame, 500 clinical trials started and 142 clinical trials were completed, i.e. on
average, 28.4% percent of trials that started reached the finish line to date. In the past 5 years, 195 clinical trials started and 86 clinical trials were completed. i.e. 44.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
2005-04-08
2009-09-07
Completed
829
Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD
2002-07-01
2003-03-01
Completed
141
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
2003-07-01
2004-12-01
Terminated
80
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
2003-06-01
2004-11-01
Terminated
180
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
2006-04-01
2007-08-01
Completed
1,695
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
2006-06-01
2013-10-01
Completed
372
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
2004-06-01
2006-03-01
Terminated
Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
2005-06-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Catholic University of Korea, Seoul St.Mary's Hospital" #1 sponsor was "The Catholic University of Korea" with 47 trials, followed by "Hoffmann-La Roche" with 35 trials
sponsored, "Janssen Research & Development, LLC" with 33 trials sponsored, "Seoul St. Mary's Hospital" with 33 trials sponsored and "Pfizer"
with 33 trials sponsored. Other sponsors include 601 different institutions and
companies that sponsored additional 259 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Catholic University of Korea, Seoul St.Mary's Hospital"
#1 collaborator was "CardioVascular Research Foundation, Korea" with 32 trials as a collaborator, "Seoul St. Mary's Hospital" with 16 trials as a collaborator, "The Catholic University of Korea" with 13 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 11 trials as a collaborator and "AstraZeneca" with 9 trials as a collaborator. Other collaborators include 373 different institutions and companies that were
collaborators in the rest 234 trials.
Clinical Trials Conditions at The Catholic University of Korea, Seoul St.Mary's Hospital
According to Clinical.Site data, the most researched conditions in "The Catholic University of Korea, Seoul St.Mary's Hospital" are
"Coronary Artery Disease" (31 trials), "Multiple Myeloma" (23 trials), "Gastric Cancer" (18 trials), "Hypertension" (14 trials) and "Atrial Fibrillation" (12 trials). Many other conditions were trialed in "The Catholic University of Korea, Seoul St.Mary's Hospital" in a lesser frequency.
Clinical Trials Intervention Types at The Catholic University of Korea, Seoul St.Mary's Hospital
Most popular intervention types in "The Catholic University of Korea, Seoul St.Mary's Hospital" are "Drug" (575 trials), "Device" (72 trials), "Biological" (60 trials), "Other" (58 trials) and "Procedure" (42 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (121 trials), "Paclitaxel" (18 trials), "Carboplatin" (17 trials), "Cisplatin" (15 trials) and "Dexamethasone" (13 trials). Other intervention names were less common.
Clinical Trials Genders at The Catholic University of Korea, Seoul St.Mary's Hospital
The vast majority of trials in "The Catholic University of Korea, Seoul St.Mary's Hospital" are
713 trials for "All" genders, 39 trials for "Female" genders and 31 trials for "Male" genders.
Clinical Trials Status at The Catholic University of Korea, Seoul St.Mary's Hospital
Currently, there are 282 active trials in "The Catholic University of Korea, Seoul St.Mary's Hospital".
4 are not yet recruiting,
163 are recruiting,
114 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 346 completed trials in The Catholic University of Korea, Seoul St.Mary's Hospital,
undefined suspended trials,
and 45 terminated clinical trials to date.
Out of the total trials that were conducted in The Catholic University of Korea, Seoul St.Mary's Hospital, 83 "Phase 1"
clinical trials were conducted, 162 "Phase 2" clinical
trials and 301 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 90 trials, and there were
also 92 trials that are defined as “Not Applicable".